Skip to main content

Incannex welcomes world-leading psychedelics experts to advisory board

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Incannex Healthcare Ltd (ASX:IHL, NASDAQ: IXHL) director Peter Widdows tells Proactive the company has appointed three world-renowned psychedelic therapy and science experts to its Clarion Clinics Group Advisory Board. The Clarion Clinics Groups Pty Ltd is a collaborative venture between Incannex and three leading Australian psychedelics experts - Dr Paul Liknaitzky, Professor Suresh Sundram and Sean O’Carroll.

Contact Details

Proactive Investors

Jonathan Jackson

+61 413 713 744

Jonathan@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  238.63
+11.98 (5.29%)
AAPL  331.76
-6.43 (-1.90%)
AMD  482.69
+53.13 (12.37%)
BAC  61.65
+0.58 (0.94%)
GOOG  334.17
-1.59 (-0.47%)
META  530.80
-54.81 (-9.36%)
MSFT  454.59
+64.05 (16.40%)
NVDA  193.17
+3.16 (1.66%)
ORCL  124.90
+7.16 (6.08%)
TSLA  305.38
+7.06 (2.37%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.